IRLA

39.7050.59%
LD

Leone D. Patterson

Director

Ms. Leone D. Patterson is Independent Director of Kalaris Therapeutics, Inc. from April 3, 2025. She is Director of IRulya Therapeutics Inc. (formerly known as Quince Therapeutics, Inc.) since October 8, 2026. He served as Independent Non-Executive Director of Oxford Biomedica plc since May 01, 2023 until December 31. 2024. She serves as Chief Financial Officer, Executive Vice President and Chief Business Officer of Zymeworks inc. since joining in September 1, 2024. She was Chief Financial and Business Officer at Tenaya Therapeutics, Inc. since June 2021 until August 14, 2024. Prior to joining Tenaya in June 2021, she was President at Adverum Biotechnologies, Inc. since December 2019 until June 2021. She was Principal Accounting Officer of Adverum Biotechnologies, Inc. since January 28, 2021 until June 2021 and had been its Chief Financial Officer, Principal Financial Officer since February 2021 until June 2021. Ms. Patterson joined Adverum in June 2016. She served as the Chief Executive Officer and Director of Adverum Biotechnologies, Inc. from May 2018 to June 15, 2020 and from October 12, 2018 to June 15, 2020 respectively. Ms. Patterson was Chief Financial Officer at Adverum Biotechnologies, Inc. until April 2019 and served as Senior Vice President since February 2018 until May 3, 2018. Ms. Patterson served as Independent Director at Eliem Therapeutics, Inc. since March 2021 until January 19, 2023. She served as the President of Adverum Biotechnologies, Inc. since October 12, 2018 until November 2018. She serves as Director at Nkarta, Inc. since April 2020. She served as the Interim President and Chief Executive Officer of Adverum Biotechnologies, Inc. since May 3, 2018 until October 12, 2018. Ms. Patterson has Finance and Accounting experience. Ms. Patterson served as the Chief Financial Officer of Diadexus, Inc. from March 16, 2015 to June 10, 2016. Ms. Patterson served as the Chief Financial Officer and Vice President of Transcept Pharmaceuticals, Inc. from June 25, 2012 to October 30, 2014. Ms. Patterson served as Chief Financial Officer and Vice President of Paratek Pharmaceuticals, Inc. until October 30, 2014. She served as Principal Accounting Officer at Transcept Pharmaceuticals, Inc. From November 2010 to June 2012, she served as a Vice President and Corporate Controller at Net App. From November 2010 to June 2012, Ms. Patterson served as Vice President and Global Corporate Controller of NetApp, Inc. From July 2007 to 2010, she served as Vice President of Finance at Exelixis. Ms. Patterson served as Vice President of Global Business Planning Analysis of the Vaccines and Diagnostics Division at Novartis AG from April 2006 to July 2007, where she oversaw the business planning and analysis function for the Vaccines and Diagnostics Division. From 1999 to 2006, she held several positions at Chiron, Corp., including as its Vice President since November 2003 and Corporate Controller since 2001. Ms. Patterson joined Chiron Corporation in 1999 as Director of Special Projects in the corporate finance group. Ms. Patterson worked at KPMG LLP as a Senior Manager in the San Francisco audit practice. She served at KPMG LLP from 1989 to 1999. Ms. Patterson was a Certified Public Accountant. Ms. Patterson received a B.S. degree in Business Administration and Accounting from Chapman University and an Executive M.B.A. and graduated with honors from St. Mary's College. Ms. Patterson is also a Certified Public Accountant (inactive status).

Positions